The Biosimilar Pipeline Seams Seem to be Bursting

Reinke, T.

Managed Care 26(3): 24-25

2017


ISSN/ISBN: 1062-3388
PMID: 28510516
Document Number: 692511
The biosimilar segment of the pharmaceutical industry is on fire. Some 700 biosimilars are at some stage of development, and more than 660 companies are involved in some way in the biosimilars land rush. Still, only a handful may get on the market in the next few years.

Document emailed within 1 workday
Secure & encrypted payments